NIRxcell Stent System is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease associated with stenotic lesions in de novo native coronary arteries (length ≤ 30mm) with a reference vessel diameter of 2.50mm to 4.00mm.
- Superior Deliverability with Novel Spring Tip
- Narrowest Strut Width from Dual-Pattern Strut Design
- Best-in-class Conformability*
- Exceptional Clinical Outcomes with TLR rate of 5.1% at 9 months
- Thermo-Treated Reinforced Hypotube for improved hub-to-tip force transfer